Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jagadish Chandrabose Sundaramurthi

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Experimental and Molecular Pathology|December 1, 2009
Immunological and proteomic analysis of preparative isoelectric focusing separated culture filtrate antigens of Mycobacterium tuberculosisAnbarasu Deenadayalan, Jagadish Chandrabose Sundaramurthi, Alamelu Raja
Immunogenetics|July 20, 2012
Resistance-associated epitopes of HIV-1C-highly probable candidates for a multi-epitope vaccineJagadish Chandrabose Sundaramurthi, Soumya Swaminathan, Luke Elizabeth Hanna
AIDS Research and Human Retroviruses|August 29, 2012
HLA-B*27:05-specific cytotoxic T lymphocyte epitopes in Indian HIV type 1CJagadish Chandrabose Sundaramurthi, V D Ramanathan, Luke Elizabeth Hanna
Microbial Pathogenesis|May 16, 2018
Antibacterial activity of flavonoid isolated from Trianthema decandra against Pseudomonas aeruginosa and molecular docking study of FabZRajarathinam Geethalakshmi, Jagadish Chandrabose Sundaramurthi, Dronamraju V L Sarada
Bioinformation|November 30, 2011
Molecular docking of azole drugs and their analogs on CYP121 of Mycobacterium tuberculosisJagadish Chandrabose Sundaramurthi, Swetha Kumar, Kannayan Silambuchelvi, et al.
Vaccine|September 11, 2017
HLA based selection of epitopes offers a potential window of opportunity for vaccine design against HIVJagadish Chandrabose Sundaramurthi, Manickam Ashokkumar, Soumya Swaminathan, et al.
Tuberculosis (Edinburgh, Scotland)|November 21, 2016
Recent developments in genomics, bioinformatics and drug discovery to combat emerging drug-resistant tuberculosisSoumya Swaminathan, Jagadish Chandrabose Sundaramurthi, Alangudi Natarajan Palaniappan, et al.
Bioinformation|March 10, 2017
Docking-based virtual screening of known drugs against murE of Mycobacterium tuberculosis towards repurposing for TBSridharan Brindha, Jagadish Chandrabose Sundaramurthi, Devadasan Velmurugan, et al.
Tuberculosis (Edinburgh, Scotland)|September 28, 2011
Informatics resources for tuberculosis--towards drug discoveryJagadish Chandrabose Sundaramurthi, S Brindha, T B K Reddy, et al.
Medical Hypotheses|June 3, 2017
Bioinformatics approach to prioritize known drugs towards repurposing for tuberculosisSridharan Brindha, Savariar Vincent, Devadasan Velmurugan, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Experimental and Molecular Pathology|December 1, 2009
Immunological and proteomic analysis of preparative isoelectric focusing separated culture filtrate antigens of Mycobacterium tuberculosisAnbarasu Deenadayalan, Jagadish Chandrabose Sundaramurthi, Alamelu Raja
Immunogenetics|July 20, 2012
Resistance-associated epitopes of HIV-1C-highly probable candidates for a multi-epitope vaccineJagadish Chandrabose Sundaramurthi, Soumya Swaminathan, Luke Elizabeth Hanna
AIDS Research and Human Retroviruses|August 29, 2012
HLA-B*27:05-specific cytotoxic T lymphocyte epitopes in Indian HIV type 1CJagadish Chandrabose Sundaramurthi, V D Ramanathan, Luke Elizabeth Hanna
Microbial Pathogenesis|May 16, 2018
Antibacterial activity of flavonoid isolated from Trianthema decandra against Pseudomonas aeruginosa and molecular docking study of FabZRajarathinam Geethalakshmi, Jagadish Chandrabose Sundaramurthi, Dronamraju V L Sarada
Bioinformation|November 30, 2011
Molecular docking of azole drugs and their analogs on CYP121 of Mycobacterium tuberculosisJagadish Chandrabose Sundaramurthi, Swetha Kumar, Kannayan Silambuchelvi, et al.
Vaccine|September 11, 2017
HLA based selection of epitopes offers a potential window of opportunity for vaccine design against HIVJagadish Chandrabose Sundaramurthi, Manickam Ashokkumar, Soumya Swaminathan, et al.
Tuberculosis (Edinburgh, Scotland)|November 21, 2016
Recent developments in genomics, bioinformatics and drug discovery to combat emerging drug-resistant tuberculosisSoumya Swaminathan, Jagadish Chandrabose Sundaramurthi, Alangudi Natarajan Palaniappan, et al.
Bioinformation|March 10, 2017
Docking-based virtual screening of known drugs against murE of Mycobacterium tuberculosis towards repurposing for TBSridharan Brindha, Jagadish Chandrabose Sundaramurthi, Devadasan Velmurugan, et al.
Tuberculosis (Edinburgh, Scotland)|September 28, 2011
Informatics resources for tuberculosis--towards drug discoveryJagadish Chandrabose Sundaramurthi, S Brindha, T B K Reddy, et al.
Medical Hypotheses|June 3, 2017
Bioinformatics approach to prioritize known drugs towards repurposing for tuberculosisSridharan Brindha, Savariar Vincent, Devadasan Velmurugan, et al.
Pageof 3